Overview
- 74 inspections across 61 sites are on record.
- 169 Form 483 observations are attributed to this investigator.
- Most recent recorded activity is 2026-06-03.
At a glance
Inspections
74
Sites
61
Observations
169
Career since
Apr 2016
Recent inspections
Most recent inspections in the published record.
| Site | Date | Category | Form 483 |
|---|---|---|---|
| Annovex Pharma, Inc. | 3 Jun 2026 | Human Drugs | View 483 → |
| Frontida BioPharm Inc | 2 Apr 2026 | Human Drugs | |
| Quotient Sciences - Philadelphia LLC | 2 Mar 2026 | Human Drugs | |
| FairyGene, Inc. | 15 Jan 2026 | Human Drugs | View 483 → |
| Sharp Packaging Services, LLC | 21 Nov 2025 | Human Drugs |
Sites inspected
Annovex Pharma, Inc.Lorton, United States1 insp.
Frontida BioPharm IncPhiladelphia, United States1 insp.
Quotient Sciences - Philadelphia LLCGarnet Valley, United States1 insp.
FairyGene, Inc.Bristol, United States1 insp.
Sharp Packaging Services, LLCAllentown, United States1 insp.
Co-investigators
Investigators who share inspections with this person.
Rachael O Oyewole6 shared
Craig D Zagata6 shared
Ruben C Quintana4 shared
Anastasia M Shields4 shared
Kristina L Conroy4 shared
Lisa B Orr4 shared
David A Oluwo4 shared
Matthew R Noonan4 shared
Lu Chen3 shared
Evan Tong3 shared
Full investigator report
Get the verbatim findings behind Christina K Theodorou's 169 observations
Source 483 PDFs, verbatim observations, and how each site responded, so your team knows what they cite before they arrive.
- New inspections and Form 483s, mapped to the CFR citation
- Warning letter outcomes, and the citation patterns they repeat
- Their co-investigators, so no surprises about who shows up on site